First Indian Study on Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Advanced Peritoneal Carcinomatosis Secondary to Epithelial Ovarian Cancer

被引：9

作者：

Somashekhar S.P. ^{[1
]}

Rajagopal A.K. ^{[1
]}

Zaveri S.S. ^{[1
]}

Chandrashekhar R.K. ^{[1
]}

Rauthan A. ^{[2
]}

Rakshit S.H. ^{[3
]}

机构：

[1] Department of Surgical Oncology, Manipal Comprehensive Cancer Center, Manipal Hospital, #98, HAL Airport Road, Bangalore

[2] Department of Medical Oncology, Manipal Comprehensive Cancer Center, Manipal Hospital, #98, HAL Airport Road, Bangalore

[3] Pathology Department, Manipal Hospital, #98, HAL Airport Road, Bangalore

来源：

Indian Journal of Gynecologic Oncology | 2018年 / 16卷 / 2期

关键词：

Chemotherapy; CRS; HIPEC; Indian patients; Intraperitoneal; Ovarian cancer; Peritoneal carcinomatosis; PIPAC;

D O I：

10.1007/s40944-018-0193-x

中图分类号：

学科分类号：

摘要：

Background: Peritoneal carcinomatosis is a common evolution in ovarian cancers. Although majority of patients have option of cytoreductive surgery and HIPEC, a few with recurrent cancers who are not eligible for curative approach can undergo pressurized intraperitoneal aerosol chemotherapy (PIPAC) which is an emerging field of research with major therapeutic potential. It is a safe and innovative approach, which enhances the effect of chemotherapy without major toxicity. Methods: Between June 2017 and December 2017, 9 PIPAC applications in 3 patients with pressurized aerosol solution of cisplatin and doxorubicin every 6 weeks at 37 °C and 12 mmHg for 30 min were performed. The patient demographics, perioperative findings, adverse events, and outcomes were prospectively recorded. Results: Nine PIPAC administrations were performed in 3 patients with peritoneal carcinomatosis secondary to ovarian cancer. The median hospital stay was 1 day. There were no major perioperative complications. CTCAE grade 2 was observed in 1 patient, for abdominal pain and nausea. Renal and hepatic functions were not impaired. Of the 3 patients, two patients had partial response, and one had stable disease. Conclusion: Our results show the feasibility and safety of PIPAC in Indian patients with advanced ovarian cancer. The procedure has low morbidity with no mortality with short learning curve. It can be easily adopted as a palliative option apart from systemic chemotherapy. © 2018, Association of Gynecologic Oncologists of India.

引用

共 20 条

[1]

Sugarbaker P.H., Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology, Cancer Treat Res, 82, pp. 79-100, (1996)

[2]

Sugarbaker P.H., Ryan D.P., Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?, Lancet Oncol, 13, 8, pp. e362-e369, (2012)

[3]

Beckert S., Struller F., Grischke E.M., Glatzle J., Zieker D., Konigsrainer A., Konigsrainer I., Surgical management of peritoneal surface malignancy with respect to tumour type, tumour stage and individual tumour biology, Zentralblchir, (2013)

[4]

Jacquet P., Stuart O.A., Chang D., Sugarbaker P.H., Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration, Anticancer Drugs, 7, pp. 596-603, (1996)

[5]

Facy O., Al Samman S., Magnin G., Et al., High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study, Ann Surg, 256, pp. 1084-1088, (2012)

[6]

Esquis P., Consolo D., Magnin G., Et al., High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis, Ann Surg, 244, pp. 106-112, (2006)

[7]

Minchinton A.I., Tannock I.F., Drug penetration in solid tumours, Nat Rev Cancer, 6, pp. 583-592, (2006)

[8]

Tempfer C.B., Winnekendonk G., Solass W., Et al., Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study, Gynecol Oncol, 137, 2, pp. 223-228, (2015)

[9]

Nadiradze G., Giger-Pabst U., Zieren J., Strumberg D., Solass W., Reymond M.A., Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis, J Gastrointest Surg, 20, 2, pp. 367-373, (2016)

[10]

Demtroder C., Solass W., Zieren J., Strumberg D., Giger-Pabst U., Reymond M.A., Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis, Colorectal Dis, 18, 4, pp. 364-371, (2016)

← 1 2 →